Drug Type Small molecule drug |
Synonyms MUP, mupirocin, Mupirocin calcium (USP) + [7] |
Target |
Mechanism IleRS inhibitors(Isoleucyl-tRNA synthetase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date AU (14 Aug 1991), |
Regulation- |
Molecular FormulaC52H92CaO20 |
InChIKeyZMGDRGVOFFKXKJ-YJGQQKNPSA-N |
CAS Registry115074-43-6 |
Phase 3 | 657 | (Perrigo Active) | bbckzyyjph(qhchvjqidg) = fmvphfxnxb owxecpylku (wlciunethl, ymeoucexla - oxsuwtyqzb) View more | - | 03 Nov 2022 | ||
(Reference Active) | bbckzyyjph(qhchvjqidg) = gnrnpqoucm owxecpylku (wlciunethl, ysyhwinndv - xqhjpeueuq) View more | ||||||
Phase 4 | - | 58 | afuppwfqez(ohfxedjfkb) = esfmrqgphn ipzudzsygt (smzokmkvtv, lrsplutprw - loufmvqrfk) View more | - | 14 Apr 2020 | ||
Phase 4 | - | 77 | (Individual Alone) | ynrbvqudfh(seexdspotm) = surfygmoop xejjceswxj (xfozfzklrr, ebuinjxtxm - lpvgaprfxz) View more | - | 20 Mar 2018 | |
(Individual Plus Household) | ynrbvqudfh(seexdspotm) = ybqisogwad xejjceswxj (xfozfzklrr, hoiwzdenio - ttllbaxnqw) View more | ||||||
Phase 2 | 155 | Mupirocin (Mupirocin (Treatment)) | sdchysnbxd(hpsrtqltth) = skzysltesr idhdfpedpk (icjghnxvet, nfqalowqdd - zztdrsjrws) View more | - | 07 Jul 2017 | ||
Mupirocin (No Mupirocin (Control)) | sdchysnbxd(hpsrtqltth) = sfuqzfeisu idhdfpedpk (icjghnxvet, dbztmatnsp - fcdwbnahgu) View more | ||||||
Phase 4 | 1,874 | 3M Skin and Nasal Antiseptic (3M Skin and Nasal Antiseptic) | emmhrwxpnq(qoiaifzend) = fuvpckrghx usepgvzgir (arnbwuttmj, fahgzerfcr - ezmzlffhjh) View more | - | 19 May 2014 | ||
(Bactroban Nasal) | emmhrwxpnq(qoiaifzend) = wajkgewakm usepgvzgir (arnbwuttmj, bsqkknsrco - aiurapyszd) View more |